Literature DB >> 9806943

Residual structure in the Alzheimer's disease peptide: probing the origin of a central hydrophobic cluster.

S Zhang1, N Casey, J P Lee.   

Abstract

BACKGROUND: . Structure-function studies on the Alzheimer's disease peptide sh w that a central hydrophobic cluster - Abeta(17-21), LVFFA - is a prominent structural feature linked to plaque competence. The origin and stability of this cluster was probed in a 17-residue fragment which includes flanking residues that potentially help stabilize the cluster.
RESULTS: After residue substitution, the measurement of pKas, amide exchange rates and other NMR data show that any coulombic interactions between His14 and Glu22 are not required for the stability of the central hydrophobic cluster. In contrast, a single substitution within the cluster disrupts its integrity and causes the largest pKa shift for flanking residues, while increasing the solvent accessibility of the backbone.
CONCLUSIONS: The integrity of the structurally dominant cluster relies primarily upon local hydrophobic interactions, rather than on interactions between the sidechains of charged flanking residues. Moreover, the conformational disposition of the cluster affects the pKas of flanking residues, underscoring its structural dominance.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9806943     DOI: 10.1016/S1359-0278(98)00054-6

Source DB:  PubMed          Journal:  Fold Des        ISSN: 1359-0278


  16 in total

1.  Investigating how peptide length and a pathogenic mutation modify the structural ensemble of amyloid beta monomer.

Authors:  Yu-Shan Lin; Gregory R Bowman; Kyle A Beauchamp; Vijay S Pande
Journal:  Biophys J       Date:  2012-01-18       Impact factor: 4.033

2.  Stoichiometry and affinity of the human serum albumin-Alzheimer's Aβ peptide interactions.

Authors:  Julijana Milojevic; Giuseppe Melacini
Journal:  Biophys J       Date:  2011-01-05       Impact factor: 4.033

3.  Subresidue-Resolution Footprinting of Ligand-Protein Interactions by Carbene Chemistry and Ion Mobility-Mass Spectrometry.

Authors:  Gaoyuan Lu; Xiaowei Xu; Gongyu Li; Huiyong Sun; Nian Wang; Yinxue Zhu; Ning Wan; Yatao Shi; Guangji Wang; Lingjun Li; Haiping Hao; Hui Ye
Journal:  Anal Chem       Date:  2019-12-11       Impact factor: 6.986

4.  Role of the familial Dutch mutation E22Q in the folding and aggregation of the 15-28 fragment of the Alzheimer amyloid-beta protein.

Authors:  Andrij Baumketner; Mary Griffin Krone; Joan-Emma Shea
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-11       Impact factor: 11.205

5.  Effects of familial Alzheimer's disease mutations on the folding nucleation of the amyloid beta-protein.

Authors:  Mary Griffin Krone; Andrij Baumketner; Summer L Bernstein; Thomas Wyttenbach; Noel D Lazo; David B Teplow; Michael T Bowers; Joan-Emma Shea
Journal:  J Mol Biol       Date:  2008-06-04       Impact factor: 5.469

6.  Simulation study of the structure and dynamics of the Alzheimer's amyloid peptide congener in solution.

Authors:  F Massi; J W Peng; J P Lee; J E Straub
Journal:  Biophys J       Date:  2001-01       Impact factor: 4.033

7.  Amino acid substitutions [K16A] and [K28A] distinctly affect amyloid β-protein oligomerization.

Authors:  Matjaž Žganec; Nicholas Kruczek; Brigita Urbanc
Journal:  J Biol Phys       Date:  2016-05-07       Impact factor: 1.365

8.  Probing the origins of increased activity of the E22Q "Dutch" mutant Alzheimer's beta-amyloid peptide.

Authors:  F Massi; J E Straub
Journal:  Biophys J       Date:  2001-08       Impact factor: 4.033

9.  In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692-->Gly) Alzheimer's disease.

Authors:  D M Walsh; D M Hartley; M M Condron; D J Selkoe; D B Teplow
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

10.  Charge states rather than propensity for beta-structure determine enhanced fibrillogenesis in wild-type Alzheimer's beta-amyloid peptide compared to E22Q Dutch mutant.

Authors:  Francesca Massi; D Klimov; D Thirumalai; John E Straub
Journal:  Protein Sci       Date:  2002-07       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.